Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Jeffrey, Crowley"'
Autor:
Melinda Gooderham, Ronald Vender, Jeffrey Crowley, H. Chih-Ho Hong, Meghan Feely, Alyssa Garrelts, Kyoungah See, Bruce Konicek, Lawrence Green
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 2, Pp 441-451 (2024)
Abstract Introduction When assessing the effect of a therapy for psoriasis (PsO), it is important to consider speed of response and cumulative response. However, responses among biologics may differ by body regions. This post hoc analysis compares sp
Externí odkaz:
https://doaj.org/article/f00c3bb6c4ff40e9a728bb090f968f07
Autor:
Bruce Strober, April Armstrong, Simone Rubant, Manish Patel, Tianshuang Wu, Huzefa Photowala, Jeffrey Crowley
Publikováno v:
Journal of Dermatological Treatment, Vol 33, Iss 7, Pp 2991-2996 (2022)
Background Psoriasis is often treated with biologic therapies. While many patients see improvement in their symptoms with treatment, some achieve only partial success. Objective and Methods In this post-hoc analysis we assess Psoriasis Area Severity
Externí odkaz:
https://doaj.org/article/b960321c78854342a658ec3be18dff02
Autor:
Boni Elewski, Alan Menter, Jeffrey Crowley, Stephen Tyring, Yang Zhao, Simon Lowry, Stephen Rozzo, Alan M. Mendelsohn, Jeffrey Parno, Kenneth Gordon
Publikováno v:
Journal of Dermatological Treatment, Vol 31, Iss 8, Pp 763-768 (2020)
Background: Tildrakizumab is a high-affinity, humanized, IgG1 κ, anti-interleukin-23 monoclonal antibody approved for moderate-to-severe plaque psoriasis. Objectives: This analysis examined whether tildrakizumab’s week-28 efficacy can be sustained
Externí odkaz:
https://doaj.org/article/84c339470f9543d89cc146be5b10a8c5
Autor:
Andrew Blauvelt, Diamant Thaçi, Kim A Papp, Vincent Ho, Kamran Ghoreschi, Byung Soo Kim, Megan Miller, Yaung-Kaung Shen, Yin You, Daphne Chan, Jenny Yu, Ya-Wen Yang, Mark G Lebwohl, Alice B Gottlieb, Jeffrey Crowley, Peter Foley
Publikováno v:
British Journal of Dermatology.
The VOYAGE 1 and 2 studies of guselkumab in moderate-to-severe psoriasis are among the first studies of biologics to include patients with a history of malignancy. In these studies, 18 guselkumab-treated patients had a history of malignancy (excludin
Autor:
Suzanne Murray, Jeffrey Crowley, Melinda J. Gooderham, Alan Kivitz, Vinod Chandran, Sophie Péloquin, Paul P. Doghramji, Christie Freeman, Patrice Lazure
Publikováno v:
Journal of Psoriasis and Psoriatic Arthritis. 7:35-43
Background The paradigm shift toward biologic medications in psoriasis care requires healthcare providers (HCPs) to become acquainted with mechanisms of action and safety profiles of these new treatments to confidently use them in practice. A better
Autor:
Andrew Blauvelt, Diamant Thaci, Kim Papp, Vincent Ho, Kamran Ghoreschi, Byung Soo Kim, Megan Miller, Yaung-Kaung Shen, Yin You, Jenny Yu, Ya-Wen Yang, Jeffrey Crowley, Peter Foley
Publikováno v:
SKIN The Journal of Cutaneous Medicine. 6:s2
N/A
Autor:
Janusz Jaworski, Xiaojiang Zhan, R. Stevens, Paul Bird, Adele R. Vessey, Christopher J Edwards, C. Birbara, Jeffrey Crowley, Francisco J. Blanco, Jacob A. Aelion
Publikováno v:
Annals of the Rheumatic Diseases
RUC. Repositorio da Universidade da Coruña
instname
RUC. Repositorio da Universidade da Coruña
instname
ObjectiveTo evaluate apremilast treatment in patients with active psoriatic arthritis, including current skin involvement, despite prior therapy with conventional disease-modifying antirheumatic drugs and/or biologic agents.MethodsPatients (N=505) we
Autor:
Randall M. Stevens, ChiaChi Hu, Jeffrey Crowley, Francisco J. Blanco, Christopher J. Edwards, C. Birbara
Publikováno v:
Rheumatology. 53:i138-i139
Autor:
Francisco J. Blanco, C. Birbara, ChiaChi Hu, Randall M. Stevens, Christopher J. Edwards, Jeffrey Crowley
Publikováno v:
Rheumatology. 53:i139-i140
Autor:
Jeffrey, Crowley
Publikováno v:
Journal of drugs in dermatology : JDD. 9(8)
The scalp is one of the regions of the body most commonly affected by psoriatic lesions. While the head represents only 10 percent of the body's surface area, the consequences of scalp psoriasis are disproportionate to the area, as it can be seriousl